These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9389423)

  • 1. Cardiac disease in diabetic end-stage renal disease.
    Foley RN; Culleton BF; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Diabetologia; 1997 Nov; 40(11):1307-12. PubMed ID: 9389423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Am J Kidney Dis; 1996 Jul; 28(1):53-61. PubMed ID: 8712222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and risk factors for left ventricular disorders in chronic uraemia.
    Parfrey PS; Foley RN; Harnett JD; Kent GM; Murray DC; Barre PE
    Nephrol Dial Transplant; 1996 Jul; 11(7):1277-85. PubMed ID: 8672023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    J Am Soc Nephrol; 1996 May; 7(5):728-36. PubMed ID: 8738808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Murray DC; Barre PE
    Kidney Int; 1996 May; 49(5):1379-85. PubMed ID: 8731103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
    Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
    Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.
    Bentata Y; Haddiya I; Latrech H; Serraj K; Abouqal R
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):392-402. PubMed ID: 23538374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cardiac morbidity and mortality in dialysis patients.
    Foley RN; Parfrey PS
    Curr Opin Nephrol Hypertens; 1994 Nov; 3(6):608-14. PubMed ID: 7881984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study).
    Martínez-Castelao A; Gòrriz JL; Garcia-López F; López-Revuelta K; De Alvaro F; Cruzado JM;
    J Nephrol; 2004; 17(4):544-51. PubMed ID: 15372417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).
    Villar E; Chang SH; McDonald SP
    Diabetes Care; 2007 Dec; 30(12):3070-6. PubMed ID: 17848610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocalcemia, morbidity, and mortality in end-stage renal disease.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Hu L; O'Dea R; Murray DC; Barre PE
    Am J Nephrol; 1996; 16(5):386-93. PubMed ID: 8886175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.
    Chou YH; Lin WC; Chen YM
    Diabetes Res Clin Pract; 2019 Feb; 148():144-151. PubMed ID: 30641169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac disease in diabetic patients with renal disease.
    Foley R
    Acta Diabetol; 2002 Apr; 39 Suppl 1():S9-14. PubMed ID: 12038700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors Before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients.
    Tsur N; Menashe I; Haviv YS
    Sci Rep; 2019 Jul; 9(1):10633. PubMed ID: 31337801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy as a cause of end-stage renal disease in Tabuk area, Saudi Arabia: a four-year study.
    El Minshawy O; Ghabrah T; El Bassuoni E
    Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1105-9. PubMed ID: 25193923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease.
    Villar E; Polkinghorne KR; Chang SH; Chadban SJ; McDonald SP
    Diabetologia; 2009 Dec; 52(12):2536-41. PubMed ID: 19756481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.
    Foley RN; Parfrey PS; Harnett JD; Kent GM; Martin CJ; Murray DC; Barre PE
    Kidney Int; 1995 Jan; 47(1):186-92. PubMed ID: 7731145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.